Why the FDA Was Wrong to Delay Authorization of Vaccines for Kids Under 5

Authors

Govind C. Persad

Publication Date

2-17-2022

Document Type

Article

Keywords

FDA, Vaccines, Pediatrics, Pfizer, BioNTech

Abstract

The Food and Drug Administration made the wrong call when it announced last week that it will delay authorization of the Pfizer-BioNTech vaccine for children under 5.

The move is likely to leave young children without access to the shots for two months or more. The FDA and Centers for Disease Control and Prevention should be removing roadblocks to vaccinating young children, not erecting them.

Copyright Date

2022

Copyright Statement / License for Reuse

All Rights Reserved.

Publication Statement

User is responsible for all copyright compliance.

Publication Title

Washington Post

Recommended Citation

Govind Persad et al., Opinion, Why the FDA Was Wrong to Delay Authorization of Vaccines for Kids Under 5, Wash. Post (Feb. 17, 2022), https://www.washingtonpost.com/opinions/2022/02/17/why-fda-was-wrong-delay-authorization-vaccines-kids-under-5/.